Wells Fargo analyst Daniel Politzer and his team have decided to upgrade DraftKings Inc. shares, despite the stock already having risen about 180% this year. In an upgrade from equal weight to overweight, Politzer explains that he doesn't want to miss out on a potential further rally in the stock. Politzer's decision is based on DraftKings' impressive performance in its latest … [Read more...] about Wells Fargo Upgrades DraftKings Stock, Expects Further Rally
Forex News
UPS Shares Set to Snap Losing Streak
Shares of United Parcel Service Inc. (UPS) are showing signs of a rebound, surging 0.7% in afternoon trading on Monday. The package delivery giant is poised to end a five-day losing streak as investors eagerly anticipate the release of its second-quarter financial results. Earnings Projections The much-awaited results will be disclosed on Tuesday, August 8, at 6 a.m. Eastern … [Read more...] about UPS Shares Set to Snap Losing Streak
Union Files Unfair Labor Practice Charge Amid Violence against Hotel Workers
The union representing hotel workers in Los Angeles has taken action, filing an unfair labor practice charge with the National Labor Relations Board. The charge comes as workers and organizers continue to face violence during protests and their fight for new contracts. Striking for Higher Wages and Better Benefits Thousands of hospitality workers have been on strike in the area … [Read more...] about Union Files Unfair Labor Practice Charge Amid Violence against Hotel Workers
Turbulent Earnings Season for U.S. Airlines
Domestic Demand Slowdown Impacts U.S. Airlines The recent earnings season has brought about turmoil for U.S. airlines, resulting in a reevaluation of the industry's outlook. A significant point of concern is the downturn in domestic demand, which has been highlighted by major carriers as they head into the second half of the year. Pressure on Domestic Airlines Expected to … [Read more...] about Turbulent Earnings Season for U.S. Airlines
Promising Results for Novo Nordisk’s Obesity Drug
Novo Nordisk, a Danish pharmaceutical company, saw its shares rise by 16% after the announcement of positive results from a five-year study on its obesity drug. The study revealed that the drug, marketed as Wegovy, reduces the risk of major adverse cardiovascular events in overweight or obese adults by 20%. Semaglutide, the active component of Wegovy, proved to have a safe and … [Read more...] about Promising Results for Novo Nordisk’s Obesity Drug
